Read + Share
Zhao S, Cheng Y, Wang Q, Li X, et al. Sacituzumab tirumotecan in advanced non-small-cell lung cancer with or without
EGFR mutations: phase 1/2 and phase 2 trials. Nat Med 2025 Apr 10. doi: 10.1038/s41591-025-03638.
PMID: 40210967
|
 |
|
Zhao S, Cheng Y, Wang Q, Li X, et al. Sacituzumab tirumotecan in advanced non-small-cell lung cancer with or without
EGFR mutations: phase 1/2 and phase 2 trials. Nat Med 2025 Apr 10. doi: 10.1038/s41591-025-03638.
PMID: 40210967
|
|
|
|